MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Movement Disorders In Children With Monoamine Neurotransmitter Disorders

    M. Ben Hafsa, H. Benrhouma, T. Ben Younes, H. Klaa, A. Zioudi, Z. Miladi, I. Ben Youssef-Turki, I. Kraoua (Tunis, Tunisia)

    Objective: To describe clinical, para-clinical, therapeutic and evolutionary characteristics of movement disorders (MD) and oculogyric crises (OC) in children with monoamine neurotransmitter disorders (MND) Background:…
  • 2024 International Congress

    Movement Disorders Associated with Infectious Encephalitis in Pediatric Patients

    M. Mnif, H. Benrhouma, T. Benyounes, H. Klaa, Z. Miladi, A. Zioudi, I. Turki, I. Kraoua (Tunis, Tunisia)

    Objective: The objective of our study is to report the clinical and imaging profile of a cohort of pediatric patients with movement disorders (MDs) associated…
  • 2024 International Congress

    Jaw Clonus Masquerading as Jaw Tremor in a case of Amyotrophic Lateral Sclerosis (ALS)

    A. Boddu (Little Rock, USA)

    Objective: To highlight the importance of distinguishing jaw clonus from jaw tremor which can be a useful sign in clinical diagnosis by reporting a case…
  • 2024 International Congress

    Daily-life Sensor Based Measurement of Tremor Presence and Amplitude

    K. Ocran, D. Hepp, J. van Hilten, V. Exadaktylos, R. Weijer (Leiden, Netherlands)

    Objective: To evaluate the association between conventional clinical ratings of tremor and one week sensor-based monitoring  of tremor in patients with Parkinson’s disease (PwPD). Background:…
  • 2024 International Congress

    Classification of Tremor and Myoclonus: An Explainable Machine Learning Approach

    E. vd Brandhof, I. Tuitert, A M. vd Stouwe, JW. Elting, J. Dalenberg, M. Biehl, M. Tijssen (Groningen, Netherlands)

    Objective: Providing a proof of concept for the classification of movement disorders using explainable machine learning applied to power spectra derived from accelerometry recordings. Background:…
  • 2024 International Congress

    Axial Tremor does not correlate with Poor Balance in Essential Tremor

    C. Flavin, E. Stulberg, M. Szilagyi, S. Rahimpour, P. Kassavetis (Salt Lake City, USA)

    Objective: To explore the correlation between the severity of axial tremor and balance disorder in Essential Tremor (ET). Background: ET is a heterogeneous disorder and…
  • 2024 International Congress

    Functional neurological disorders might be a frequent cause of slow orthostatic tremor: insights from a case series.

    A. Querejeta-Coma, L. Yupanqui-Guerra, A. Gómez-Domínguez, C. Ordas-Bandera (Móstoles, Spain)

    Objective: To study the clinical and electrophysiological characteristics of series of patients with slow orthostatic tremor (sOt) Background: sOT is characterized by tremor <13Hz affecting…
  • 2024 International Congress

    Prevalence of Phosphorylated Alpha-Synuclein in Skin Biopsies of Essential Tremor Patients

    S. Bellows, N. Vanegas Arroyave, J. Jankovic (Housont, USA)

    Objective: To examine the prevalence of phosphorylated alpha-synuclein in nerve fibers in patients with essential tremor (ET) and ET plus. Background: Although Essential Tremor (ET)…
  • 2024 International Congress

    Characteristics and Treatment Patterns of Patients Newly Diagnosed With Essential Tremor: A Retrospective Claims Database Analysis in the US

    J. Williams, R. Pahwa, L. Barbato, J. Lin, F. Tefos, A. Sillah, S. Thomas, F. Geng, Y. Pan, J. Friderici, S. Shah (Bakersfield, USA)

    Objective: To understand patient characteristics and real-world medication patterns of patients with essential tremor (ET) being initiated on treatment in the US. Background: ET is…
  • 2024 International Congress

    Age of Onset and Choice of First-line Therapy in Essential Tremor Patients

    F. Jamal, G. Jackson, A. Sarwar, P. Mandava (Houston, USA)

    Objective: The purpose of this study is to examine the effect of age of onset on the selection of initial medication for symptomatic management of…
  • « Previous Page
  • 1
  • …
  • 513
  • 514
  • 515
  • 516
  • 517
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley